GlassScriptPhysician profile
Philip Mark Wakefield
NPI 1417042862
$987.46
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $503.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.75 | 2019-2020 | |
| Duchesnay USA Incorporated | $120.76 | 2019 | |
| Astellas Pharma US INC | $117.43 | 2019 | |
| Roche Diagnostics Corporation | $100.33 | 2019-2020 | |
| Amgen INC. | $97.20 | 2019-2020 | |
| Lilly USA, LLC | $92.73 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.03 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $43.55 | 2019-2020 | |
| Bausch Health US, LLC | $36.08 | 2019-2020 | |
| Pfizer INC. | $35.42 | 2019-2020 | |
| Coopersurgical, INC. | $34.03 | 2020 | |
| Therapeuticsmd, INC. | $23.62 | 2019 | |
| Novo Nordisk INC | $17.15 | 2020 | |
| Currax Pharmaceuticals LLC | $15.43 | 2020 | |
| Radius Health, INC. | $14.76 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $13.46 | 2020 | |
| Lupin INC. | $12.62 | 2020 | |
| Eisai INC. | $11.58 | 2020 | |
| Ethicon US, LLC | $11.27 | 2020 | |
| Allergan, INC. | $11.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Wakefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.